Status:
COMPLETED
Diffusion Tensor Breast MRI (DTI)
Lead Sponsor:
University Health Network, Toronto
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The breast MRI is used in the preoperative scenario to evaluate the extension of a newly diagnosed breast cancer and to screen the contralateral breast. The scan consists of a series of images taken a...
Eligibility Criteria
Inclusion
- Female of any race, ethnicity and lifetime risk.
- Eighteen years or older.
- Known recent diagnosis of a breast cancer and normal clinical breast exam of the contralateral side.
- Self-detected lump suspicious for breast cancer that it has not been biopsied yet.
Exclusion
- Inability to understand the consent form
- Pregnant or nursing
- Currently taking tamoxifen, evista (raloxifene), or an aromatase inhibitor for adjuvant therapy or chemoprevention
- Physically unable to lie down on her belly for at least 10 minutes.
- Have had benign needle biopsy of the breast performed within 3 months, or breast surgery within 1 year prior to MRI exam.
Key Trial Info
Start Date :
April 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2020
Estimated Enrollment :
267 Patients enrolled
Trial Details
Trial ID
NCT02812589
Start Date
April 1 2016
End Date
April 1 2020
Last Update
April 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Cancer Centre, University Health Network, 610 University Ave.
Toronto, Ontario, Canada, M5G 2M9